Investigation of antiarrhythmic activity of liposomal cytochrome C
DOI:
https://doi.org/10.15587/2519-4852.2017.104954Keywords:
arrhythmia, Cytochrome C, liposomes, technology of liposomes obtaining, liposomal Cytochrome CAbstract
Aim. The aim of research was to study antiarrhythmic activity of released and liposomal forms of Cytochrome C.
Methods. The liposomes were obtained by lipid film method followed by homogenization at high pressure. The particles size and the degree of inclusion were determined. Arrhythmia was studied using the Barium chloride model. Arrhythmia occurrence and duration in each animal was recorded by the electrocardiographic method. Barium chloride, according to the conventional method, was administered at a dose of 4 mg/kg. Amiodarone was used as a reference sample at a dose of 5 mg/ kg. Both forms of Cytochrome C were administered intravenously at a dose of 10 mg/kg.
Results. Technology for obtaining the Cytochrome C liposomal form was offered by the authors; the substance inclusion into the liposome composition (not less than 95%) and the obtained nanoparticles sizes (100–170 nm) were studied. A significant decrease in arrhythmia period during the use of Cytochrome C was observed. The liposomal Cytochrome C (10 mg/kg) shows a higher activity than the released form of the drug and reduces the arrhythmia period compared to the control more than 2 times.
Conclusion. Liposomal Cytochrome C is a promising antiarrhytmicagent due to its low toxicity compared to Amiodarone having numerous adverse effects. In the further research, it is planned to study the dose-dependent effect of the liposomal Cytochrome C and membrane-stabilizing properties in model experiments with coronary heart disease and arrhythmia
References
- Vashchenko, V. I., Khanson, K. P., Shabanov, P. D. (2005). Tsitokhrom C kak lekarstvennoe sredstvo: proshloe, nastoyashchee, budushchee. Obzory po klinicheskoy farmakologii i lekarstvennoy terapii, 4 (1), 27–37.
- Vladimirov, Yu. A., Proskurnina, E. V., Alekseev, A. V. (2013). Molekulyarnye mekhanizmy apoptoza. Struktura kompleksa tsitokhroma C s kardiolipinom. Biokhimiya, 78 (10), 1391–1404.
- Boyarinov, G. A., Yakovlev, A. Yu., Tezyaeva, S. A. et. al. (2001). Primenenie tsitokhroma C dlya profilaktiki reperfuzionnykh povrezhdeniy miokarda pri protezirovanii klapanov serdtsa v usloviyakh iskusstvennogo krovoobrashcheniya. Vestnik khirurgii, 1, 15–20.
- Ballyuzek, M. F., Semenova, I. G. (2013). Ratsional'nyy vybor terapii preparatami metabolicheskikh grupp pri ishemicheskoy bolezni serdtsa. Prakticheskaya meditsina, 3, 47–51.
- Semenova, I. G., Ballyuzek, M. F., Novikov, Yu. A., Tugusheva, F. A. (2013). Effektivnost terapii bol'nykh khronicheskoy serdechnoy nedostatochnost'yu i narusheniyami ritma serdtsa preparatom tsitokhrom C. Farmateka, 10, 86–91.
- Semenova, I. G. (2012). Metabolicheskaya terapiya v pozhilom i starcheskom vozraste pri narusheniyakh ritma serdtsa i khronicheskoy serdechnoy nedostatochnosti. Zdorove – osnova chelovecheskogo potentsiala: problemy i puti ikh resheniya, 1, 458–459.
- Okovityy, S. V., Gayvoronskaya, V. V., Kulikov, A. N., Shulenin, S. N. (2009). Klinicheskaya farmakologiya: izbrannye lektsii. Moscow: GEOTAR- Meditsina, 608.
- Shanskaya, A. I., Puchkova, S. M. (2013). Liposomal'nye nanosistemy na osnove soevykh fosfolipidov kak konteyner dlya lekarstvennykh sredstv. Transfuziologiya, 14 (2), 66–75.
- Khromov, A. S. (2016). Liposomal'nye preparaty – realizatsiya nanotekhnologiy v meditsine. Farmakologhija ta likarsjka toksykologhija, 2, 14–23.
- Balykova, L. A., Balashov, V. P., Markelova, I. A., Al'myasheva, M. I. (2007). Preparaty metabolicheskogo tipa deystviya v lechenii aritmiy serdtsa. Saransk: Referent, 134.
- Stefanov, A. V. (Ed.) (2002). Doklinicheskie issledovaniya lekarstvennykh sredstv. Kyiv: Avitsenna, 568.
- Mironov, A. N., Bunatyan, N. D. (2012). Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv. Chast' pervaya. Moscow: Grif i K, 944.
- Skorobogatova, T. A., Panurkin, V. I., Ivashev, M. N. (2011). Issledovaniya antiritmicheskoy aktivnosti anilokaina i lidokaina pri khlorbarievoy aritmii. Kubanskiy nauchno-meditsinskiy vestnik, 5, 155–160.
- Borisova, E. Ya., Zverev, D. M., Fomicheva, G. A. et. al. (2010). Antiritmiki novogo pokoleniya klassa funktsional'no zameshchennykh aminov. Mikroelementy v meditsine, 11 (3-4), 79–83.
- Shobolov, D. L., Krasnopol'skiy, Yu. M., Ul'yanov, A. M. et. al. (2015). Pat. No. 022183 Evraziyskoe patentnoe vedomstvo. Sposob polucheniya liposomal'noy formy tsitokhroma C. No. 201201592; declareted: 30.11.2012; published: 24.12.2015, 9.
- Katsay, O. G., Prokhorov, V. V., Grigoreva, G. S., Krasnopolsky, Yu. M. (2016). Rozroblennya ta validaciya metodyky vyznachennya stupenya inkapsulyaciyi cytoxromu С u liposomax. Farmatsevtychnyi zhurnal, 5, 69–73.
- Shanskaya, A. I., Krivoruchko, B. I., Bulusheva, E. V. (1998). Pat. No. 2110990 RU. Liposomal'naya vezikula s Tsitokhromom C. MPK А61К9/127. No. 94027343/14; declareted: 14.07.1994; published: 20.05.1998.
- Kovalenko, V. N. (Ed.) (2016). KOMPENDIUM 2016 – lekarstvennye preparaty. Kyiv: Morion, 2416.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Darya Pylypenko, Aleksey Katsai, Vitaliy Prokhorov, Natalya Konakhovich, Anna Grigoreva, Yuriy Krasnopolsky
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
